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Many organisms produce small proteins which exhibit antimicrobial activities.  In 
recent decades, the biological role of antimicrobial peptides (AMP) has been recognized 
as the main factor in the defense mechanisms against a broad range of pathogenic microbes. 
The increased worldwide incidence of microbial resistance to antibiotics and pesticides, 
makes AMPs promising alternative for the control of microbial disease. 
In the last decades, synthetically designed novel non-natural APMs have become an option 
for use in the improvement of agriculture for crops. The synthetic AMPs have enhanced 
activities against a wide spectrum of pathogens with low non-specific toxicity, good 
stability, and bioavailability. Exploring the potential of the AMPs in transgenic crops could 
lead to the development of new and improved cultivars which are resistant to various 
pathogenic diseases.  
In the present study, four different non-plant multi-domain lytic peptide genes, which code 
for antimicrobial peptides and are expressed in Nicotiana benthamiana tobacco plants were 
tested against three fungal pathogens: Sclerotinia sclerotiorum, Rhizoctonia solani, and 
Pythium sp. Detached-leaf bioassay was performed for the transgenic plants carrying multi-
domain lytic peptide constructs (ORF13, RSA1, CN77, ORF12), transgenic vector control 
 
 
plants (1234), and wild control plants (WT) against the three fungal pathogens. Symptom 
area of each leaf was measured with high accuracy. Data was recorded and processed by 
statistical analyses. The results showed that transgenic plant lines ORF13 and RSL1 have 
substantial resistance to Sclerotinia sclerotiorum infection, producing significant smaller 
symptom area compared to controls: vector plant line 1234 and wild type WT. However, 
these lines were not effective against two other fungal pathogens Rhizoctonia solani, and 
Pythium sp
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INTRODUCTION 
 
Antimicrobial peptides (AMPs) are natural components of many living organisms’ 
defense system. The common characteristic of these peptides is their ability to suppress a 
wide range of pathogenic microbes. AMPs are peptides which consist of up to 100 amino 
acids (AAs). In nature, AMPs are molecules with a high degree of biochemical and 
structural variability, which strongly correlates with the environmental diversity and the 
richness of living organisms. Despite their variability, AMPs share common characteristics 
such as positively charged AAs and the existence of hydrophobic or hydrophilic secondary 
structures. The cationic nature of AMPs determines their ability to interact selectively with 
negatively charged microbial surfaces, which result in disruption or inhibition of microbial 
cells. Based on their secondary structure, AMPs can be grouped into the following types: 
−helical, −sheets, −loop and random coil. −Helical structure is a form of a right 
hand-spiral protein conformation. To form this shape, each N-H backbone group in the 
protein donates a hydrogen bond to the C=O backbone group of the protein. The distance 
between the bonds is three to four residues along the protein sequence. As in the −helical, 
−sheets assembly consists of two or three hydrogen bonds which connect two parallel 
−strands molecules. In the random coil structure, a group of protein strands is bonded 
randomly with an indefinite sequence. 
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Mode of Action of Antimicrobial Peptides 
Bacteria Cell Wall Interaction 
Unlike the higher living organisms, bacterial membrane is often surrounded by a 
tight cell wall composed of lipopolysaccharides (LPS), phospholipids and peptidoglycans 
(PGN). The presence of an outer membrane in gram-negative bacteria is a typical 
characteristic that does not exist in gram-positive bacteria. Both bacterial types have 
periplasmic space or periplasm. In gram-positive bacteria periplasm is located between the 
cell wall and the cytoplasmic membrane. Periplasmic space in Gram-negative bacteria is 
situated between the plasma membrane and the outer membrane. 
The cell wall of both bacterial types contains PGN layers.  The gram-positive bacteria cell 
wall is made of several PGN layers with a thickness of about 40-80 nm. In Gram-negative 
bacteria, the PGN layer is 7-8 nm thick and is locked in the periplasmic space (1). The 
outer membrane of Gram-negative bacteria is composed of a lipid bilayer with 
phospholipid inner leaflet and lipopolysaccharide outer leaflet (2–4). 
AMPs can penetrate the gram-negative bacterial cell wall by a charge-exchange 
mechanism. During this process, the cationic peptides compete with Ca2+ and Mg2+ and 
bind to the lipopolysaccharide (LPS) layer of the outer membrane. Later, these peptides 
penetrate the bacterial cells by an interaction with the cytoplasmic membrane 
phospholipids. Due to their hydrophobic domains, peptides translocated across the 
bacterial membrane, entering into the cell and binding to DNA and other cell membranes 
(5). 
AMPs interaction with gram-positive bacterial cell wall is not well understood. AMPs can 
disrupt the synthesis of PGN by interfering the enzymatic processes of the synthesis. AMPs 
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also target the negatively charged cell wall components such as teichoic acid and 
lipoteichoic acid. The semisynthetic lipoglycopeptide oritavancin can be used as a model 
interaction of AMPs against the gram-positive bacterial cell wall. It displays the effect of 
inhibition of PGN synthesis (1). 
 
Fungal Cell Wall Interaction 
The fungal cell wall is a layered structure, with the inner layers performing a 
predominantly mechanical function, while the outer layers are associated with the 
physiological features of particular fungal species. In most species, the inner cell wall is 
composed of covalently attached branched β-(1, 3) glucan with chitin. This branched 
glucan is tied to proteins and polysaccharides which compose outer cell wall, and their 
conformation varies with the fungal species (6). 
AMPs interaction with the fungal cell wall varies depending on the AMPs type. Some 
AMPs disrupt the function and structure of the cell wall. Defensin NP-1 binds tightly to 
the chitin layer, which can lead to selective plasma membrane lysis.  Nikkomycin can block 
chitin biosynthesis. Echinocandin and its synthetic analogs can inhibit synthesis of 
branched β-(1,3) glucan (7). 
 
Phospholipid Membrane Interaction 
Antimicrobial peptides undergo conformational changes when they interact with a 
target phospholipid membrane. In water the AMPs structure is hydrophilic. However, their 
conformation has to be changed because they must expose a hydrophobic area to the lipidic 
constituent of the membrane. The conformation change happens when a monomeric 
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peptide adopts a random structure in solution but gains an amphipathic structure when it is 
reaching the membrane. The other scenario is when peptides form an oligomer, they 
exposed their hydrophilic regions to the solution and bury their hydrophobic regions in a 
formed lumen. Upon reaching the membrane surface, the oligomer reverses its organization 
such that the hydrophobic part is exposed to a lipid constituent of the cell membrane (8). 
Antimicrobial peptides act in different ways when they interact with the membranes, but 
the main action mode of AMPs is the permeabilization of phospholipid membranes. This 
process is described through several models: toroidal-pore model, carpet model, and barrel-
stave model. 
Toroidal-Pore Model 
In this model, the lipid monolayer is bent continuously by attached alpha helix 
AMPs.  To forming a pore, the hydrophobic surface of the peptide interacts with lipid head 
groups of the membrane (9). In the formed toroidal pore, the polar faces of the peptide are 
associated with the polar head groups of the lipid constituents (10). Lipids constituting the 
pore tilt from the normal lamellar structure, and connect the two leaflets of the membrane, 
creating an uninterrupted bend from top to bottom in a mode of the toroidal hole (11). 
Carpet Model 
In this model, peptides are accumulated on the phospholipid membrane by strong 
electrostatic forces. The anionic phospholipid head groups of the plasma membrane attract 
the cationic antimicrobial peptides, which are oriented parallel to the membrane surface. 
Peptides are attached to the anionic phospholipid head groups at the multiple sites covering 
the membrane surface in carpet-like mode.  At high peptide concentration, surface-attached 
peptides are capable of disrupting the membrane bilayer (11). 
5 
 
Barrel-Stave Model 
In this model alpha-helix peptides are linked together in an oligomer molecule which 
forms transmembrane pores. The hydrophilic surfaces of the peptides are oriented to the 
lumen of the pore; the hydrophobic surface is oriented to the lipid layer of the cell 
membrane. The transmembrane pore formation process starts with binding of peptide 
monomers to the phospholipid membrane surface. Subsequently, the monomers are 
inserted into the lipid core of the membrane. The peptide monomer concentration is critical 
for the pore size formation. The high accumulation of the monomers increases the pore size 
and consequently leads to cytoplasmic cell content release (12). 
 
Intracellular Targets Interaction 
In addition to the ability to interact with cell walls and the cell membranes, there 
are more indications for specific interactions of the AMPs with intracellular targets. The 
most common effect of AMPs is the inhibition of both cell wall and protein synthesis due 
to DNA and RNA binding. By translocating to the cytoplasm, AMPs can alter the 
cytoplasmic membrane formation by inhibition of main metabolic processes such as cell 
wall formation, enzyme activity, nucleic acid and protein synthesis (13). 
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History of Antimicrobial Peptides 
In 1939 an antimicrobial peptide named gramicidins was isolated from the 
prokaryotic cells of Bacillus brevis (14). Gramicidin, a heterogeneous mixture of six 
antibiotic peptides, was successfully used to treat infected wounds on the guinea-pig skin 
which proved their potential for clinical use (15). The gramicidin was the first 
commercially produced AMPs (16). 
Eukaryotic organisms also produce AMPs. Previous research in plants showed the 
existence of four different groups of AMPs which play a significant role in the plant defense 
system (17).  These groups include plant defensins, lipid transfer peptides, thionins, and 
chitin-binding peptides (17). 
The increase of multidrug-resistance in microbial pathogens in the early 1960s raised the 
interest in host defense molecules (18, 19). Studies with human neutrophils during that 
period proved that the oxygen-independent mechanisms which are not part of the adaptive 
immune system are responsible for the elimination of pathogenic bacteria. The mechanisms 
are based on cationic proteins contained in the neutrophil cells (20, 21). 
The isolation of bombinin AMP in 1962 from the orange speckled frog Bombina variegata, 
is the first reported animal antimicrobial peptide (22). At the same time during the 1960s 
the antimicrobial peptide, lactoferrin was isolated from milk (23).  Several research papers 
from the late 1970s and 1980s reported isolation of AMPs from rabbits’ and humans’ 
leukocytes; these groups of antimicrobial peptides are well known nowadays as 
−defensins (24–27). 
In an experiment carried out in 1981 by Boman et al. pupae of the moth Hyalophora 
cecropia were injected with bacteria. Later, inducible cationic antimicrobial peptides 
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named P9A and P9B were isolated from the hemolymph of the pupae. The proteins were 
sequenced, characterized, and renamed as cecropins. The cecropins were the first reported 
−helical AMPs (28). 
In the late 1980s, −defensins and θ-defensins were isolated from bovine granulocytes 
(29). The first anionic AMPs was isolated and identified from the frog species Xenopus 
laevis in the mid-1990s (30). During the same period, more evidence had proved the view 
that lysozyme activities are non-enzymatic with a similar mode of action to that of 
antimicrobial peptides (31). These findings convinced some authors to believe that AMPs 
are the main defense factor of organisms lacking an adaptive immune system (32). These 
theories were confirmed in an experiment with the fruit fly, Drosophila melanogaster, 
during the mid-1990s. After the deletion of the genes responsible for encoding AMPs, the 
fly became susceptible to fungal infections (33). The extensive study of the AMPs 
encompasses not only plants and insects but also the invertebrate organisms which do not 
possess an adaptive immune system (34–37). Most of the current findings and 
understanding for the AMPs function and structure are based on experiments conducted 
with amphibian skin secretions, which are a rich source of AMPs (38–41). Research work 
proved that AMPs are typical for all multicellular organisms (42), and these peptides have 
an essential role in the mammalian immune system (43–46). 
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Antimicrobial Peptides as Inhibitors of Plant Pathogenic Microorganisms in 
Transgenic Plants 
Diseases caused by microbial pathogen constitute a significant problem in crop 
production in the United States and worldwide. Pesticide application is a common practice 
to combat crop diseases. In the United States, over one billion pounds of agrochemicals are 
used annually for pest control, and the worldwide usage is approximately 5.6 billion pounds 
per year (47). The systemic use of pesticides harms the environment and increases the risk 
of pesticide resistance incidents. Therefore, alternative means to combating crop diseases 
are being tested and employed.  
Genetically engineering techniques have shown excellent results in plant-pathogen 
inhibition in recent decades. Successfully created commercial lines of genetically modified 
(GM) crops which are resistant to a broad range of pathogens have proven the effectiveness 
of this alternative approach. For example, experiments with model plants contained gene 
construct with AMPs coding sequences have been carried out by some authors. Results  
have shown the great capability of the AMPs genes constructs for protection against 
diseases caused by plant pathogens (48–53). 
In a carried study, human lactoferrin cDNA has been used for tobacco plants Nicotiana 
tabacum transformation (48). The integration of cDNA in the plant genome was analyzed 
by Southern, Northern, and Western blots. After inoculation with the bacterial pathogen 
Ralstonia solanacearum, most transgenic plants showed substantial delays of bacterial wilt 
symptoms. The positive relationship between the expressed lactoferrin gene and disease 
resistance was proved by enzyme-linked immunosorbent assay.  
9 
 
Further examples include investigations of the expression of the lactoferrin (LF) gene in 
transgenic tomato plants (49). The plants were tested for resistance to the pathogen 
Ralstonia solanacearum Smith that causes bacterial wilt in tomato. Susceptible tomato line 
F7926-96 was transformed by Agrobacterium transformation with modified LF cDNA and 
gene introgression confirmed by Southern blot. Additionally, lactoferrin expression was 
detected by northern and western blots. In T1 and T2 generations, kanamycin resistance 
was observed based on Mendelian segregation verifying a single locus insertion. 
Furthermore, Southern blot analysis showed a single corresponding band of LF cDNA in 
T1 and T2 kanamycin resistant plants. The two transgenic tomato lines inoculated with the 
pathogen (1x107 and 1x108 colony-forming units (CFU)) exhibited an early resistance and 
subsequent susceptibility. The survival rate until maturity was observed at 44% to 55% of 
the plants when they are inoculated with 1x105 CFU.  These results demonstrated the 
potential of the lactoferrin AMP gene for control of bacterial wilt of tomato. 
Bovine lactoferrin cDNA construct was used for transformation of wheat plants, and the 
transformants were inoculated with head blight disease fungus Fusarium graminearum 
(54). Significant reduction of disease incidence was observed in the transgenic plants. 
Highly susceptible cultivar Bobwhite expressed high resistance compared to control 
Bobwhite plants and two untransformed commercial wheat cultivars (Wheaton and ND 
2710). The positive correlation between lactoferrin gene expression and the levels of 
disease resistance were proved by an ELISA experiment.  
Two tomato proteins Snakin-2 (SN2) and extensin-like protein (ELP) were over-expressed 
in transgenic tomato plants to test their ability to induce resistance to Clavibacter 
michiganensis subsp. michiganensis (Cmm) (51). The tomato plants, cultivar Mountain 
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Fresh, were transformed via an Agrobacterium tumefaciens transformation. Tomato 
transgenic lines that accumulated a high level of SN2 or ELP mRNA showed significant 
tolerance to Cmm by a delay of the wilt symptoms and a reduction in the size of canker 
lesions compared to control. In the transgenic lines over-expressing SN2 or ELP, bacterial 
populations were significantly lower (100-10,000-fold) than in control plants. The results 
suggested a potential biotechnological application of these two defense proteins. 
Substantial advances have been made to develop efficient methods for synthesis of new 
antimicrobial peptides and their derivatives. These designed peptide modifications can be 
assayed for the desired antimicrobial activity. By molecular engineering techniques, their 
properties can be improved regarding the pathogen specificity, the toxic side effect and the 
range of action.  
The novel AMPs originate from naturally occurring peptides via synthetic modifications. 
It is well known that the most natural AMPs have nonspecific toxicity against plant or 
animal cells at certain concentration levels. This adverse effect can be avoided by 
modulation and redesigned of the natural AMPs. Membrane-active AMPs cecropins, 
magainins, and melittin have toxic properties, which make their practical use very difficult 
(55). Cecropins are the first class of AMPs in which activity ratio against microbes versus 
toxicity to plant cells, was modulated. The primary sequences of cecropin B analogs:  SB-
37 and Shiva-1 were engineered in a way that reduced their toxicity to plant protoplasts 
(52, 56).  
 Transgenic plants with broad-spectrum resistance to bacterial and fungal phytopathogens 
were created by combining two or more AMPs genes. In one study, a synthetic gene coding 
cecropin-melittin cationic hybrids chimera (MsrA1) is expressed in two potato cultivars  
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Desiree and Russet Burbank (53). The potato cultivars demonstrated very high resistance 
to bacterial and fungal phytopathogens.  
Expression of multiple genes in a single open reading frame (ORF) is an alternative 
approach for combining desirable AMPs in a single polyprotein. This method is exploited 
from several animal Picornavirus and plant Potyviruses. Their polyproteins are processed 
co-translationally and post-translationally to mature forms by virus-encoded proteases 
(57). In an experiment, the Foot-and-mouth disease virus (FMDV) 2A protein, which is 
responsible for the ‘cleavage’ at its carboxyl-terminus, is used as cleavage of artificial 
polyproteins (58). Multiple copies of chloramphenicol acetyltransferase (CAT) and 
−glucuronidase (GUS) genes were fused in a single open reading frame (ORF) with a 
copy of the 2A protein gene between them. The ORF construct was expressed in transgenic 
tobacco plants. Consistent detection in the transgenic tobacco of CAT and GUS proteins 
with efficiency ranged from 80% to 100% proved that FMDV 2A protease functioned 
properly in plant cells. This work proved that creating a single ORF gene construct with 
merged multiple AMPs genes can be used in transgenic plants for efficient protection 
against various plant pathogens.  
In an effort to achieve stronger resistance than our previous work with lactoferrin and 
lactoferricin, we fused the lactoferricin domain of lactoferrin with multiple active domains 
of other AMPs using FMDV 2A protease. Transgenic tobacco and tomato plants were 
generated from these constructs and grown several generations to obtain homozygous lines. 
In this work four selected lines were tested for resistance against three economically 
important fungal pathogens. 
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MATERIALS AND METHODS 
 
Multi-domain lytic peptide constructs and transgenic lines 
Previous work in our laboratory generated several multi-domain constructs by 
fusing two synthetic or naturally occurring AMPs with lactoferricin. A large number of 
transgenic tobacco and tomato lines were obtained expressing these constructs. Seeds from 
four transgenic tobacco lines were used in this work to obtain plants and to test them for 
fungal disease resistance. 
Preparation of transgenic and control Nicotiana benthamiana plants 
Seeds sterilization 
In this study, six N. benthamiana lines have been used: four transgenic lines 
containing lytic peptide genes (ORF13, RSA1, CN77, ORF12) along with one empty 
vector line containing a viral gene construct (1234) in the same binary construct, and one 
wild type control non-transgenic (WT) line. Seeds were sterilized by the following 
protocol: First seeds were placed in 2 ml Eppendorf tubes. One milliliter of 10 % solution 
of commercial bleach (NaOCl) was added to each tube. The seeds were immersed for five 
minutes. After removal of bleach from the tubes, the seeds were washed with distilled water 
three times. Washed seeds were immersed in 70% Ethanol for 30 seconds followed by three 
washes with distilled water. The distilled water was removed carefully from the Eppendorf 
tubes with a pipette. 
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Seeds Germination on Murashige-Skoog Solid Plant Media 
The seeds were placed  in magenta boxes on 50 ml Murashige-Skoog (MS) solid 
plant media (Murashige-Skoog Plant Media: MS Salt 4.3 g, B1 — Inositol ( 1 g Inositol, 
10 mg Thiamin HCl, 100 ml ddH2O) 10 ml, Millers I (6g KH2PO4, 100ml ddH2O) 3 ml, 
Sucrose 30 g and Phytagar 8 g per Liter having pH 5.8) under aseptic condition in a 
Laminar Air Flow chamber. After placement on to the MS media, the seeds were streaked 
gently with a sterile glass loop. Antibiotic Kanamycin was added (100 mg per liter) to the 
MS media for transgenic plant seeds ORF13, RSA1, CN77, ORF12 and empty vector 
control 1234. No antibiotics were added in MS media for the wild type control (WT) plant 
seeds.  
Magenta boxes were placed in a plant growth chamber at 26 °C. The first germination was 
detected ten days after placing the seeds on MS media. The plants were kept in the magenta 
boxes for forty-five days after germination. 
           
Transfer of the seedlings from magenta boxes to pots  
After forty-five days of growth in magenta boxes, the plants were transplanted in 
500 cm3 pots filled with soil. Each pot was filled with approximately 400 cm3 steam-
dissinfested potting soil (The potting mix was prepared in the UNL Plant Pathology 
Greenhouse staff). A single plant was placed in each pot. Ten plants were prepared for each 
transgenic line and the wild type control. The pots were watered gently after planting. All 
plants were placed in a room with a steady temperature of 23 °C, ~30% relative humidity, 
and artificial lighting with a day/night ratio of 14h/10h.  
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Neomycin phosphotransferase II Enzyme-linked-Immunosorbent Assay (NPTII 
ELISA)  
Neomycin phosphotransferase II (NPTII) is a selectable marker gene used in the 
transgenic lines ORF13, RSA1, CN77, ORF12, and empty vector control 1234. Seven days 
after the seedlings transfer to the pots, the presence of the NPTII protein product was 
qualitatively evaluated by an ELISA assay using an NPTII (Neomycin phosphotransferase 
II) ELISA kit from Agdia, Inc (52642 Co Rd 1, Elkhart, IN 46514). Leaf biomass from 
each plant was planced in an Eppendorf tube. The biomass was ground in the tubes with 
the presence of 1x PEB1 extraction buffer in a 1:10 ratio (tissue weight in grams: buffer 
volume in milliliters).  
One hundred l of prepared samples were dispensed into the sample wells. The negative 
control well was filled with 100 l of 1x Phosphate Buffered Saline (PBS). The sample 
wells were incubated overnight (16 hours) in the humid box at temperature 4 °C). After 
incubation, wells were washed seven times with 1x PBS buffer. 100 l enzyme conjugate 
(mixed one-part MRS-2 component to four-part 1x PBS buffer and enzyme conjugate 
bottles A and B with dilutions 1:100 for each bottle) was dispensed in the cleaned wells. 
The wells were incubated for two hours in the humid box at room temperature, ~ 23 °C. 
After the incubation, cells were washed eight times with 1x PBS buffer. 100 l of TNB 
substrate solution was dispensed in the washed wells. The wells were incubated for fifteen 
minutes in the humid box at room temperature. The results were evaluated after the 
incubation.  
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DNA extraction from plants 
The DNA from the transgenic plant lines ORF13, RSA1, CN77, ORF12, 1234 
empty vector control, and WT control was extracted by use of Thermo Fisher Plant DNAzol 
Reagent. For this procedure, the protocol provided by the manufacturer was used. The 
samples were ground using a mortar and pestle. After the pulverization, tissue was moved 
into Eppendorf tubes by using a sterile spatula. The Eppendorf tubes contained tissues were 
weighed on a scale as the scale was tared by the weight of an empty tube. 300 l plant 
DNAzol was added in each Eppendorf tube per 100 mg plant tissue, mixed thoroughly and 
incubated for five minutes at 25 °C by shaking. After incubation, 300 l of chloroform was 
added to each tube and mixed by vortex for approximately 30 seconds, then incubated for 
five minutes at 25 °C with shaking, followed by centrifugation at 12000 RPM at 4 °C for 
10 minutes. The supernatant was transferred into a fresh Eppendorf tube and mixed with 
225 l of 100 % ethanol for DNA precipitation. The samples were inverted eight times and 
then incubated at room temperature for five minutes. Subsequently, the tubes were 
centrifuged at 5000 RPM for four minutes, and the resulted supernatant was discarded and 
the DNA pellet retained.  The DNA pellets were washed with 300 l Plant DNAzol-ethanol 
wash (mix of 1 volume DNAzol with 0.75 volume 100% ethanol) and the tubes were 
vortexed and incubated for five minutes, then centrifuged at 5000 RPM for 4 minutes and 
the supernatant was removed. The same washing step was repeated two more times. 
Following the washing steps, 300 l of 75 % ethanol was added to the tubes, vortexed and 
then centrifuged at 5000 RPM for 4 minutes. The supernatant was removed, and the tubes 
were stored vertically for five minutes to remove the remaining ethanol. If some ethanol 
still existed in the tubes, it was removed with a micro-pipette. Finally, 70 l TE (Tris — 
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EDTA) buffer was added in the tubes for dissolving DNA. The tubes were stored at -80 °C 
for further analysis.  
DNA quality check 
 The quality of extracted DNA was checked by 0.8% agarose gel electrophoresis.  
Neomycin phosphotransferase II - Polymerase Chain Reaction (NPTII - PCR) 
Polymerase Chain Reaction (PCR) assay was performed for the transgenic plant 
lines ORF13, RSA1, CN77, ORF12, 1234 empty vector control, and WT control, targeting 
Neomycin phosphotransferase II (NPTII) selectable marker gene. GoTaq® Green Master 
Mix (bacterial derived Taq DNA polymerase, dNTPs, MgCl2, and reaction buffers) was 
used following manufacturer’s instructions. 2 l DNA of each transgenic plant sample was 
added to18 l reaction mixture containing 6 l ddH2O, 1 l Forward Primer, 1 l Reverse 
Primer along with 10 l GoTaq® Green Master Mix. The NPTII primers had the following 
sequence: Forward Primer; 221 5′-GAGGCTATTCGGCTATGAC-3′, Reverse Primer 921 
5′-ATCGGGAGCGGCGATACCG-3′ (The primers were designed by Mitra Lab). The 
thermal cycle was set to:  1) 94 oC for 3 min., 2) 94 oC for 30 sec., 3) 55 oC for 40 sec., 4) 
72 oC for 1 min. 40 sec., 5) 72 oC for seven min., 6) 4 oC forever, and steps two, three and 
four were repeated 35 times. The size of the amplified fragment of the NPTII tn5 gene was 
700 bp.   
Lytic peptide gene - Polymerase Chain Reaction (PCR) 
Polymerase Chain Reaction (PCR) assay was performed for the transgenic plant 
lines ORF13, RSA1, CN77, ORF12, targeting lytic peptide gene. GoTaq® Green Master 
Mix solution which contains bacterial derived Taq DNA polymerase, dNTPs, MgCl2, and 
reaction buffers has been used for this assay. Sample were prepared by the protocol 
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provided by the GoTaq® Green Master Mix manufacture.  Each sample had a final volume 
of 20 l: 2 l template DNA, 6 l ddH2O, 1 l Forward Primer, 1 l Reverse Primer, and 
10 l GoTaq® Green Master Mix. The thermal cycle was set to:  1) 94oC for 3 min., 2) 
94oC for 30 sec., 3) 55oC for 40 sec., 4) 72oC for 1min. 40 sec., 5) 72oC for 7 min., 6) 4oC 
forever, and steps 2, 3 and 4 were repeated 35 times altogether during the cycle.  
Primer’s sequences:  
Primer Sequence 
ORF13 F 5′ GGC TGT TCT TTG GGC TCT TA 3′ 
R 5′ CCC CTA ACG GAA AAC ACA GC 3′ 
RSA1 F 5′ GGA AGG GGA TTT TCT GCT GC 3′ 
R 5′ GCA GCC TCT CTT TCT TCA GC 3′ 
CN77 F 5′ GCT CTT TAC AGG GGA TGC CT 3′ 
R 5′ CCC TCA CAC CAT CCA CGA TT 3′ 
ORF12 F 5′ GCT ACT GGA ACT TCT GCT GC 3′ 
R 5′ TCA AGG CTG ATT ACC TCC CC 3′ 
Table 1. Primer sequences used to amplify Lytic peptide genes. The primers were 
designed by Mitra Lab. 
 
Agarose gel electrophoresis 
 The amplified DNA product was analyzed with 1% agarose gel (100 mg Agarose 
to 100 ml 1x Tris-Borate-EDTA buffer, and 0.6 l Ethidium Bromide solution 10 
mg/ml) electrophoresis for 100 minutes.  
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Detached-leaf bioassay 
Detached-leaf bioassay was performed to screen the transgenic plants ORF13, 
RSA1, CN77, ORF12 carrying the lytic peptide genes, empty vector control plants 1234, 
and wild type control (WT) plants against three fungal pathogens: Sclerotinia sclerotiorum, 
Rhizoctonia solani, Pythium sp.  
Rhizoctonia solani is a soil borne plant pathogenic basidiomycete fungus. It has wide range 
hosts. Rhizoctonia solani attacking primarily the roots and lower stems of plants and cause 
serious plant losses especially during seedling stage. 
Sclerotinia sclerotiorum is a plant pathogenic ascomycete fungus. It causes diseases known 
as white mold, cottony rot, soft rot or stem rot. Sclerotinia sclerotiorum has a wide host 
range in different life-stages. The disease can spread very quickly from plant to plant in the 
field. It can affect crops in the storage facilities after harvest. Common crops which are 
affected and suffer deleterious economic impacts are soybeans, cannola and peanuts.  
Pythium species are fungus-like eukaryotic microorganisms belonging to the parasitic 
oomycetes. Formally they were classified as fungi. Pythium cause diseases with economic 
importance such as root rots. 
Each transgenic variety contained ten plants. For this experiment, two detached leaves per 
plant were used. Each bioassay had three replications per plant from each line. Sixty 
experiments for each plant lines per pathogen have been performed. The pathogens were 
grown in a petri dish on a solid Potato Dextrose Agar media (PDA) (39 g PDA powder to 
1liter ddH2O autoclaved on 120 
oC for 20 minutes). The PDA powder was procured from 
Sigma-Aldrich company. Sclerotinia sclerotiorum and Rhizoctonia solani were grown for 
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four days on the media before the experiment. Pythium sp. was grown for two days on the 
media before the experiment. By using a sterile glass tube, 8 mm plugs were cut in the 
media after the growth of the pathogen for use as inoculum, see below. The detached leaves 
were placed in a plastic container with high humidity. Containers size is: 40 cm L x 31.8 
cm W x 6 cm H. The inoculation was performed by use of sterile tweezers. Plugs were 
transferred to the leaves with the pathogen on the upper surface of the plug. The plugs’ 
position on the leaves were approximately 15 mm down from the tip of each leaf. After the 
inoculation, containers were sealed with a transparent plastic wrap. Sealed containers were 
moved in a temperature-controlled room with an artificial light with a day/night ratio 
14h/10h. The experiments with Sclerotinia sclerotiorum and Rhizoctonia solani were 
incubated for three days after inoculation. The Pythium sp. experiment was incubated for 
two days after inoculation.  
Data collection 
  After incubation, leaves were photographed on a scaled photographic field. Each 
photo was processed with a graphics editor by marking the infected area of each leaf with 
a single color and the background color was changed to white. Compu Eye software was 
used (59) to measure the symptom area of each leaf quantitatively with high accuracy. The 
result of measuring the infected area as well as the total area was recorded in square 
millimeters. 
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RESULTS 
Seeds Germination on Murashige-Skoog Solid Plant Media 
The wild type control Nicotiana benthamiana seeds were germinated in magenta 
boxes with 50 ml solid Murashige-Skoog (MS) plant media. The transgenic plant seeds 
from lines ORF13, RSA1, CN77, ORF12, and transgenic vector control were germinated 
on modified MS media with Kanamycin antibiotic. The first germination was observed ten 
days after the sowing. The plants were kept in the magenta boxes for forty-five days after 
germination. During that period the plants were in good health and had an excellent growth 
rate with no signs of discoloration or fading (Fig. 1). The transgenic lytic peptide lines and 
the transgenic control line grew on Kanamycin fortified MS solid media confirming that 
the plants carried the Neomycin phosphotransferase II marker gene and linked lytic peptide 
genes (Fig. 1).   
 
 
Figure 1. Aseptically grown ORF12 transgenic tobacco lines in magenta boxes. Plants 
show normal growth and development.  
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Neomycin phosphotransferase II Enzyme-linked-Immunosorbent Assay (NPTII 
ELISA) 
The enzyme activity of NPTII selectable marker gene was evaluated qualitatively 
with an Enzyme-Linked-Immunosorbent Assay for the transgenic lines ORF13, RSA1, 
CN77, ORF12, transgenic vector control and wild type (WT) control plants. This test was 
performed using Agdia NPTII (Neomycin phosphotransferase II) ELISA kit. All transgenic 
lines: ORF13, RSA1, CN77, ORF12, vector control (1234), showed positive results for the 
existence of Neomycin phosphotransferase II marker gene in the plant's genome. 
According to the protocol, the appearance of blue color in the test wells is an indication for 
a positive result. Blue color is seen in the test wells of the transgenic plants’ lines (Fig. 2 
and Fig. 3). No color was present in the test wells for the wild type control plants and the 
negative control (Fig. 2 and Fig. 3).  
 
Figure 2. NPTII ELISA assay of transgenic and control plants. The blue colored wells 
indicate positive result. Marks on the photo correspond with the tested plant varieties.   
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Figure 3. NPTII ELISA assay of transgenic and control plants. The blue colored wells 
indicate positive result. Marks on the photo, correspond with the tested plant varieties. 
 
Plant DNA extraction  
 DNA was extracted from the transgenic plant lines ORF13, RSA1, CN77, ORF12, 
vector control (1234) and WT control. The quality of extracted DNA was tested on 0.75% 
agarose gel (750 mg Agarose to 100 ml x1 Tris-Borate-EDTA buffer and 0.6l of Ethidium 
Bromide solution 10 mg/ml) electrophoresis was for 80 minutes. The gel showed that the 
quality of the DNA was adequate (Fig. 4 to Fig. 8). 
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Figure 4. Extracted DNA was evaluated using agarose gel electrophoresis. The photo 
shows an adequate quality of the DNA. Lanes indicate the molecular weight marker (1 
Kb ladder) and genomic DNA samples from respective plants. 
 
Figure 5. Extracted DNA was evaluated using agarose gel electrophoresis. The photo 
shows an adequate quality of the DNA. Lanes indicate the molecular weight marker (1 
Kb ladder) and genomic DNA samples from respective plants. 
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Figure 6. Extracted DNA was evaluated using agarose gel electrophoresis. The photo 
shows an adequate quality of the DNA. Lanes indicate the molecular weight marker (1 
Kb ladder) and genomic DNA samples from respective plants. 
 
Figure 7. Extracted DNA was evaluated using agarose gel electrophoresis. The photo 
shows an adequate quality of the DNA. Lanes indicate the molecular weight marker (1 
Kb ladder) and genomic DNA samples from respective plants. 
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Figure 8. Extracted DNA was evaluated using agarose gel electrophoresis. The photo 
shows an adequate quality of the DNA. Lanes indicate the molecular weight marker (1 
Kb ladder) and genomic DNA samples from respective plants. 
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Polymerase Chain Reaction to amplify Neomycin phosphotransferase II selectable 
marker gene (NPTII – PCR) 
Polymerase Chain Reaction (PCR) assay was performed for the transgenic 
plant lines ORF13, RSA1, CN77, ORF12 and vector control (1234) along with WT 
control, targeting the Neomycin phosphotransferase II (NPTII) selectable marker 
gene. All samples of the transgenic plants expressed positive results for the NPTII 
marker gene. The transgenic control plants which containing vector control (1234) 
also showed positive results for the NPTII marker gene. All samples were analyzed 
on 1.00% agarose gel (1000 mg Agarose to 100 ml 1x Tris-Borate-EDTA buffer and 
0.6 l of Ethidium Bromide solution 10 mg/ml) electrophoresis at 100V and 50 
amps was for 90 minutes. All NPTII positive samples showed a clear band at 700 
bp region on the agarose gel (Fig. 9 to Fig.14). All samples from wild type N. 
benthamiana plants displayed negative results for the NPTII marker gene (Fig. 15 
and Fig. 16).  
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Figure 9. Agarose gel showing PCR amplification for NPTII gene in ORF 13 
plants. The positive samples showed a clear band at 700 bp region on the agarose 
gel. Lanes indicate the molecular weight marker (1 Kb ladder) and genomic DNA 
samples from respective plants. 
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Figure 10. Agarose gel showing PCR amplification for NPTII gene in RSA1 plants. 
The positive samples showed a clear band at 700 bp region on the agarose gel. 
Lanes indicate the molecular weight marker (1 Kb ladder) and genomic DNA samples 
from respective plants. 
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Figure 11. Agarose gel showing PCR amplification for NPTII gene in CN77 plants. 
The positive samples showed a clear band at 700 bp region on the agarose gel. 
Lanes indicate the molecular weight marker (1 Kb ladder) and genomic DNA samples 
from respective plants.   
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Figure 12. Agarose gel showing PCR amplification for NPTII gene in ORF12 plants. 
The positive samples showed a clear band at 700 bp region on the agarose gel. 
Lanes indicate the molecular weight marker (1 Kb ladder) and genomic DNA samples 
from respective plants. 
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Figure 13. Agarose gel showing PCR amplification for NPTII gene in vector control 
(1234) plants. The positive samples showed a clear band at 700 bp region on the 
agarose gel. Lanes indicate the molecular weight marker (1 Kb ladder) and genomic 
DNA samples from respective plants.   
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Figure 14. Agarose gel showing PCR amplification for NPTII gene in CN77 02 and 
CN77 07 and RSA1 02. The analysis of these samples was repeated due to missing bands 
in the previous experiments. The positive samples showed a clear band at 700 bp 
region on the agarose gel. Lanes indicate the molecular weight marker (1 Kb ladder) 
and genomic DNA samples from respective plants. 
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Figure 15. Agarose gel showing PCR amplification for NPTII gene in WT control 
plants. The negative samples showed no band at 700 bp region on the agarose gel. 
Lanes indicate the molecular weight marker (1 Kb ladder) and genomic DNA samples 
from respective plants. 
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Figure 16. Agarose gel showing PCR amplification for NPTII gene in WT control 
plants. The negative samples showed no band at 700 bp region on the agarose gel. 
Lanes indicate the molecular weight marker (1 Kb ladder) and genomic DNA samples 
from respective plants. 
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Polymerase Chain Reaction to amplify Lytic peptide genes 
Polymerase Chain Reaction (PCR) assays were employed for the transgenic plant lines 
ORF13, RSA1, CN77, ORF12. All four transgenic plant lines (ORF13, RSA1, CN77, 
ORF12) depicted positive results regarding the targeted lytic peptide genes. Table 1 shows 
the size of each gene. 
 
Gene  Size  
ORF13  213 bp 
RSA1 740 bp 
CN77 799 bp 
ORF12 390 bp 
 
Table 2. Amplified length of Lytic peptide genes. 
The PCR product was affirmed with the agarose gel electrophoresis. For all four transgenic 
plant line (ORF13, RSA1, CN77 and ORF12) samples, clear bands have been observed 
according to the expected amplicon size (Table 2), (see Fig. 17 to Fig. 21).   
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Figure 17. Agarose gel showing PCR amplification for ORF13 lytic peptide gene. The 
positive samples showed a clear band at 213 bp region on the agarose gel. Lanes 
indicate the PCR amplification from different ORF13 transgenic lines along with the 
molecular weight marker (1 kb ladder).  
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Figure 18. Agarose gel showing PCR amplification for RSA1 lytic peptide gene. The 
positive samples showed a clear band at 740 bp region on the agarose gel. Lanes 
indicate the PCR amplification from different RSA1 transgenic lines along with the 
molecular weight marker (1 kb ladder).  
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Figure 19. Agarose gel showing PCR amplification for CN77 lytic peptide gene. The 
positive samples showed a clear band at 799 bp region on the agarose gel. Lanes 
indicate the PCR amplification from different CN77 transgenic lines along with the 
molecular weight marker (1 kb ladder).  
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Figure 20. Agarose gel showing PCR amplification for ORF12 lytic peptide gene. The 
positive samples showed a clear band at 390 bp region on the agarose gel. Lanes 
indicate the PCR amplification from different ORF12 transgenic lines along with the 
molecular weight marker (1 kb ladder).  
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Figure 21. Agarose gel showing PCR amplification for CN77 and RSA1 lytic peptides 
genes. The analysis was repeated for these samples due to missing bands in previous 
experiments. The positive samples showed a clear band at 799 bp region for CN77 
and 740 bp region for RSA1 on the agarose gel. Lanes indicate the molecular weight 
marker (1 Kb ladder) and genomic DNA samples from respective plants.  
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Detached-leaf Bioassay Experiment 
 Detached-leaf bioassay was performed for the transgenic plants carrying multi-domain 
lytic peptide constructs ORF13, RSA1, CN77, ORF12, transgenic vector control plants 
(1234), and wild control plants WT, against three fungal pathogens: Sclerotinia 
sclerotiorum, Rhizoctonia solani, and Pythium sp. The infected area of each leaf was 
measured, each individual measurement was recorded in square millimeters (mm2).  
Experimental design 
The goal of this experiment is to test four transgenic lines ORF13, RSA1, CN77, 
ORF12 for resistance to three fungal plant pathogens Sclerotinia sclerotiorum, Rhizoctonia 
solani, and Pythium sp. compared to vector control (1234) and WT lines.  
Three fungal pathogens were tested sequentially for each plant. Three pseudo-replications 
have been performed for each pathogen. Two leaves from each plant were inoculated per 
experiment. The leaves from the same plants are not independent, so they are not true 
replicates, and they were named ‘pseudo-replications’. Therefore, the affected area of the 
six leaves from the same plant were averaged to one response value, then 60 responses per 
tested pathogen. The experimental design is a completely randomized design (CRD), 
randomly assigning one plant variety to one pot. 
Source of variation Degrees of freedom 
Genotype 5 
error 54  
total 60-1=59 
 
Table 3. Source of variations and degrees of freedom for the all three tested pathogens. 
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 The least square mean model equation: yij = μ + τi + 𝑒𝑖𝑗 
yij: response, i = 1,2, … , 6, j = 1, 2, … , 10 
μ: overall mean 
τi: i
th variety effect, fixed, i = 1, 2, … ,6 
eij: error term, random, eij~N(0, σ
2) 
 
Table 4. The least square mean model equation used in the statistical analyses of the 
obtained data sets.  
 
 
  
Variety name Code 
ORF13 ORF1 
RSL1 RSL1 
ORF12 ORF2 
CN77 CN77 
1234 CNTR2 
WT CNTR1 
 
Table 5. Variety codes used in the statistical analyses and charts. 
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Sclerotinia sclerotiorum experiment  
A B  
C D  
E  
Figure 22. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Sclerotinia sclerotiorum. A) ORF13 leaf with a small infection severity. B) ORF13 leaf 
with a moderate infection severity. C) ORF13 leaf with a high infection severity. D) Wild 
Type leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.   
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A B  
C D  
E  
Figure 23. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Sclerotinia sclerotiorum. A) RSL1 leaf with a small infection severity. B) RSL1 leaf with 
a moderate infection severity. C) RSL1 leaf with a high infection severity. D) Wild Type 
leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.   
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C D  
E  
Figure 24. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Sclerotinia sclerotiorum. A) CN77 leaf with a small infection severity. B) CN77 leaf with 
a moderate infection severity. C) CN77 leaf with a high infection severity. D) Wild Type 
leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.   
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A B  
C D  
E  
Figure 25. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Sclerotinia sclerotiorum. A) ORF12 leaf with a small infection severity. B) ORF12 leaf 
with a moderate infection severity. C) ORF12 leaf with a high infection severity. D) Wild 
Type leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.   
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The least square mean was calculated for all varieties (Table 6).  
   
Table 6. Estimated Least Squares Means and the Standard Error for each variety. 
 
 
  
 
Variety Least Squares Means 
Variety Estimate Standard 
Error 
DF t Value Pr >|t| Alpha Lower Upper 
CN77 830.17 111.11 53 7.47 <.0001 0.05 607.32 1053.02 
CNTR1 953.21 111.11 53 8.58 <.0001 0.05 730.36 1176.06 
CNTR2 838.23 111.11 53 7.54 <.0001 0.05 615.37 1061.08 
ORF1 537.98 111.11 53 4.84 <.0001 0.05 315.13 760.83 
ORF2 713.14 117.12 53 6.09 <.0001 0.05 478.23 948.04 
RSL1 416.18 111.11 53 3.75 0.0004 0.05 193.33 639.03 
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Chart 1. Sclerotinia sclerotiorum experiment. The estimated Least Squares Means and 
the Standard Error for each variety. The blue bars indicate estimated Squares Means for 
the varieties, the red bars indicate standard error. 
 
Chart 2. Sclerotinia sclerotiorum experiment. Least squares mean with confidential 
interval. The blue bars indicate estimated Squares Means for the varieties, the red bars 
indicate the confidence interval.  
 
49 
 
 
All four transgenic plant varieties ORF13, RSA1, CN77, ORF12 were compared to 
control wild type variety WT (Table 7). 
Differences of Variety Least Squares Means 
Adjustment for Multiple Comparisons: Dunnett 
Variety Variety Estimate Standard Error DF t Value Adj P 
CN77 CNTR1 -123.04 157.13 53 -0.78 0.8982 
CNTR2 CNTR1 -114.98 157.13 53 -0.73 0.9203 
ORF1 CNTR1 -415.23 157.13 53 -2.64 0.0444 
ORF2 CNTR1 -240.07 161.43 53 -1.49 0.4397 
RSL1 CNTR1 -537.03 157.13 53 -3.42 0.0055 
 
Table 7. Estimated mean differences between wild type WT control and the transgenic 
varieties ORF13, RSA1, CN77, ORF12. 
 
Comparing the differences of the mean, ORF1 and RSL1 variety have significant smaller 
symptom area than the wild type control variety WT (Table 7). The transgenic plants 
demonstrated less susceptibility to the pathogen. The estimated p-values RSL1 = 0.0055, 
and ORF1= 0.0444 with significance level alpha 0.05, indicates substantial difference 
comparing to the wild control variety.  
 
 
 
50 
 
The four transgenic plant varieties ORF13, RSA1, CN77, ORF12 were compared to the 
transgenic control line 1234 (Table 8). 
Differences of Variety Least Squares Means 
Adjustment for Multiple Comparisons: Dunnett 
Variety Variety Estimate Standard Error DF t Value Adj P 
CN77 CNTR2 -8.0586 157.13 53 -0.05 1.0000 
CNTR1 CNTR2 114.98 157.13 53 0.73 0.9203 
ORF1 CNTR2 -300.25 157.13 53 -1.91 0.2167 
ORF2 CNTR2 -125.09 161.43 53 -0.77 0.9020 
RSL1 CNTR2 -422.04 157.13 53 -2.69 0.0399 
 
Table 8. Estimated mean differences between transgenic vector control 1234 and the lytic 
peptide transgenic varieties ORF13, RSA1, CN77, ORF12. 
 
Comparing the differences of the mean, RSL1 variety have significant smaller symptom 
area than the transgenic vector control variety 1234 (Table 8). This transgenic variety 
demonstrated less susceptibility to the pathogen. The estimated p-values RSL1= 0.0399 
with significance level alpha 0.05, indicates substantial difference comparing to the 
transgenic control variety 1234. 
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Rhizoctonia solani experiment 
A B  
C D  
E  
Figure 26. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Rhizoctonia solani. A) ORF13 leaf with a small infection severity. B) ORF13 leaf with a 
moderate infection severity. C) ORF13 leaf with a high infection severity. D) Wild Type 
leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.   
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A B  
C D  
 
E  
Figure 27. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Rhizoctonia solani. A) RSL1 leaf with a small infection severity. B) RSL1 leaf with a 
moderate infection severity. C) RSL1 leaf with a high infection severity. D) Wild Type 
leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.   
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A B  
C D  
E  
Figure 28. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Rhizoctonia solani. A) CN77 leaf with a small infection severity. B) CN77 leaf with a 
moderate infection severity. C) CN77 leaf with a high infection severity. D) Wild Type 
leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.   
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A B  
C D  
E  
Figure 29. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Rhizoctonia solani. A) ORF12 leaf with a small infection severity. B) ORF12 leaf with a 
moderate infection severity. C) ORF12 leaf with a high infection severity. D) Wild Type 
leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.   
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The least square mean was calculated for all varieties, four lytic peptides transgenic 
ORF13, RSA1, CN77, ORF12 and two controls 1234, WT (Table 9). 
Variety Least Squares Means 
Variety Estimate Standard 
Error 
DF t Value Pr > |t| Alpha Lower Upper 
CN77 489.09 61.9526 53 7.89 <.0001 0.05 364.83 613.35 
CNTR1 390.30 61.9526 53 6.30 <.0001 0.05 266.04 514.56 
CNTR2 498.84 61.9526 53 8.05 <.0001 0.05 374.58 623.10 
ORF1 299.63 61.9526 53 4.84 <.0001 0.05 175.37 423.89 
ORF2 702.10 65.3038 53 10.75 <.0001 0.05 571.12 833.08 
RSL1 345.43 61.9526 53 5.58 <.0001 0.05 221.17 469.69 
 
Table 9. Estimated Least Squares Means and the Standard Error for each variety. 
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Chart 3. Rhizoctonia solani experiment. The estimated Least Squares Means and the 
Standard Error for each variety. The blue bars indicate estimated Squares Means for the 
varieties, the red bars indicate standard error. 
 
 
Chart 4. Rhizoctonia solani experiment. Least squares mean with confidential interval. 
The blue bars indicate estimated Squares Means for the varieties, the red bars indicate the 
confidence interval. 
57 
 
All four transgenic lytic peptide plant varieties ORF13, RSA1, CN77, ORF12 were 
compared to control wild type variety WT (Table 10). 
Differences of Variety Least Squares Means 
Adjustment for Multiple Comparisons: Dunnett 
Variety Variety Estimate Standard Error DF t Value Adj P 
CN77 CNTR1 98.7890 87.6142 53 1.13 0.6890 
CNTR2 CNTR1 108.54 87.6142 53 1.24 0.6099 
ORF1 CNTR1 -90.6706 87.6142 53 -1.03 0.7528 
ORF2 CNTR1 311.80 90.0151 53 3.46 0.0048 
RSL1 CNTR1 -44.8656 87.6142 53 -0.51 0.9810 
 
Table 10. Estimated mean differences between wild type WT control and the transgenic  
varieties ORF13, RSA1, CN77, ORF12. 
 
The estimate mean values indicates no significant smaller symptom area for the 
transgenic lines ORF13, RSA1, CN77, ORF12 comparing to control the wild type WT 
(Table 10).  
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The four transgenic lytic peptide varieties ORF13, RSA1, CN77, ORF12 were compared 
to the transgenic control line 1234 (Table 11). 
Differences of Variety Least Squares Means 
Adjustment for Multiple Comparisons: Dunnett 
Variety Variety Estimate Standard Error DF t Value Adj P 
CN77 CNTR2 -9.7526 87.6142 53 -0.11 1.0000 
CNTR1 CNTR2 -108.54 87.6142 53 -1.24 0.6099 
ORF1 CNTR2 -199.21 87.6142 53 -2.27 0.1041 
ORF2 CNTR2 203.26 90.0151 53 2.26 0.1076 
RSL1 CNTR2 -153.41 87.6142 53 -1.75 0.2887 
 
Table 11. Estimated mean differences between transgenic control 1234 and the lytic 
peptide transgenic varieties ORF13, RSA1, CN77, ORF12. 
 
The comparison analysis of the mean indicates no significant smaller symptom area for 
the transgenic lines ORF13, RSA1, CN77, ORF12 comparing to the transgenic control 
line 1234 (Table 11).  
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Pythium sp. experiment 
A B  
C  D
 
E 
Figure 30. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Pythium sp. A) ORF13 leaf with a small infection severity. B) ORF13 leaf with a 
moderate infection severity. C) ORF13 leaf with a high infection severity. D) Wild Type 
leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.  
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A B  
C D  
E  
Figure 31. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Pythium sp. A) RSL1 leaf with a small infection severity. B) RSL1 leaf with a moderate 
infection severity. C) RSL1 leaf with a high infection severity. D) Wild Type leaf with 
high infection severity. E) Vector control (1234) leaf with high infection severity.  
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A B  
C D  
E  
Figure 32. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Pythium sp. A) CN77 leaf with a small infection severity. B) CN77 leaf with a moderate 
infection severity. C) CN77 leaf with a high infection severity. D) Wild Type leaf with 
high infection severity. E) Vector control (1234) leaf with high infection severity.  
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A B  
C D  
E  
Figure 33. Comparison of detached leaves of Nicotiana benthamiana inoculated with 
Pythium sp. A) ORF12 leaf with a small infection severity. B) ORF12 leaf with a 
moderate infection severity. C) ORF12 leaf with a high infection severity. D) Wild Type 
leaf with high infection severity. E) Vector control (1234) leaf with high infection 
severity.  
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The least square mean was estimated for all varieties in the Pythium sp. experiment (Table 
12). 
Variety Least Squares Means 
Variety Estimate Standard 
Error 
DF t Value Pr > |t| Alpha Lower Upper 
CN77 1257.12 79.4394 52 15.82 <.0001 0.05 1097.71 1416.52 
CNTR1 864.45 79.4394 52 10.88 <.0001 0.05 705.05 1023.86 
CNTR2 1012.26 79.4394 52 12.74 <.0001 0.05 852.86 1171.67 
ORF1 1035.43 79.4394 52 13.03 <.0001 0.05 876.03 1194.84 
ORF2 1055.42 88.8159 52 11.88 <.0001 0.05 877.19 1233.64 
RSL1 1019.90 79.4394 52 12.84 <.0001 0.05 860.49 1179.31 
 
Table 12. Estimated Least Squares Means and the Standard Error for each variety. 
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Chart 5. Pythium sp. experiment. The estimated Least Squares Means and the Standard 
Error for each variety. The blue bars indicate estimated Squares Means for the varieties, 
the red bars indicate standard error. 
 
Chart 6. Pythium sp. experiment. Least squares mean with confidential interval. The blue 
bars indicate estimated Squares Means for the varieties, the red bars indicate the 
confidence interval. 
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The four transgenic lytic peptide plant varieties ORF13, RSA1, CN77, ORF12 were 
compared to control wild type variety WT (Table 13). 
Differences of Variety Least Squares Means 
Adjustment for Multiple Comparisons: Dunnett 
Variety Variety Estimate Standard Error DF t Value Adj P 
CN77 CNTR1 392.66 112.34 52 3.50 0.0044 
CNTR2 CNTR1 147.81 112.34 52 1.32 0.5577 
ORF1 CNTR1 170.98 112.34 52 1.52 0.4197 
ORF2 CNTR1 190.96 119.16 52 1.60 0.3708 
RSL1 CNTR1 155.44 112.34 52 1.38 0.5106 
 
Table 13. Estimated mean differences between wild type WT control and the transgenic 
varieties ORF13, RSA1, CN77, ORF12. 
 
The differences of the mean calculation indicate no significant smaller symptom area for 
the transgenic lytic peptide lines comparing to control the wild type WT (Table 13). 
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All four transgenic lytic peptide plant lines ORF13, RSA1, CN77, ORF12 were 
compared to the transgenic control line 1234 (Table 14). 
Differences of Variety Least Squares Means 
Adjustment for Multiple Comparisons: Dunnett 
Variety Variety Estimate Standard Error DF t Value Adj P 
CN77 CNTR2 244.85 112.34 52 2.18 0.1281 
CNTR1 CNTR2 -147.81 112.34 52 -1.32 0.5577 
ORF1 CNTR2 23.1702 112.34 52 0.21 0.9997 
ORF2 CNTR2 43.1524 119.16 52 0.36 0.9960 
RSL1 CNTR2 7.6358 112.34 52 0.07 1.0000 
 
Table 14. Estimated mean differences between transgenic control 1234 and the lytic 
peptide transgenic varieties ORF13, RSA1, CN77, ORF12. 
 
The statistical analysis disclosed no significant smaller symptom area for the transgenic 
lines ORF13, RSA1, CN77, ORF12 comparing to the transgenic vector control line 1234 
(Table 14). 
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DISCUSSION 
 
Many organisms produced small proteins which exhibit antimicrobial activities.  In 
recent decades, the biological role of antimicrobial peptides (AMP) was recognized as the 
main factor in the defense mechanisms against a broad range of pathogenic microbes. The 
increased incidence of antimicrobial resistance worldwide due to overuse of antibiotics and 
pesticides makes AMPs promising alternative for the treatment of microbial disease. 
In the last decades, the design of novel non-natural APMs is an option for use in agriculture 
for crops’ improvement. The designed AMPs have enhanced properties against wide 
spectrum of pathogens while they have low non-specific toxicity, good stability, and 
bioavailability. By exploring the potential of the AMPs in the crop production, could lead 
to the development of new, improved cultivars which are resistant to various pathogenic 
diseases. In the present study, four different lytic peptide genes, which codes for 
antimicrobial peptides, transformed and expressing in tobacco plants were tested against 
three fungal pathogens: Sclerotinia sclerotiorum, Rhizoctonia solani, and Pythium sp. The 
resistance of tobacco plant transformants was examined in-vivo with a detached leaves 
bioassay. 
For this study, seeds of four transgenic homozygous N. benthamiana tobacco plants 
varieties containing lytic peptide genes, one vector control transgenic non-lytic peptide 
gene tobacco plant variety, and one control wild type N. benthamiana tobacco plant variety 
were germinated on solid Murashige-Skoog (MS) plant media.  
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All transgenic varieties were tested through germination on modified MS plant media with 
Kanamycin antibiotic. The transgenic plant lines did not show any toxic effect during the 
germination and post-germination period. The observation of the plants showed normal 
growth and development. There had no discoloration or fading. That experiment proved 
the existence of NPTII selectable marker gene in the plants’ genome. 
The NPTII selectable marker gene was evaluated qualitatively with an Enzyme-Linked-
Immunosorbent Assay. The obtained results proved the NPTII selectable marker presence 
in plant genome.  The results of Enzyme-Linked-Immunosorbent Assay was confirmed by 
Polymerase Chain Reaction (PCR) Assay. All transgenic plant lines expressed positive 
results for Neomycin phosphotransferase II marker gene in their genome. The tested 
samples revealed a clear band at 700 bp region on the agarose gel. 
The DNA of the transgenic lines ORF13, RSA1, CN77, ORF12, carrying non-plant multi-
lytic peptide genes, were tested with a Polymerase Chain Reaction assay by using a specific 
primer for the respective genes. The presence of the lytic peptide genes was determined in 
all transgenic lines’ genome. The tested samples indicated clear band with accordance to 
amplified length of the lytic peptide genes.  
In a previous research, transgenic plant lines with expressed cationic peptides with broad-
spectrum antimicrobial activity demonstrated powerful resistance to bacterial and fungal 
phytopathogens (53). In a study with transgenic tobacco plants expressing an antimicrobial 
bovine lactoferrin gene, a detached leaf assay proved the potential of the AMPs against 
fungal pathogens (50).  In the current work, a detached leaf assay was performed to test the 
effect of expressed multi-lytic peptides on three fungal pathogens: Sclerotinia 
sclerotiorum, Rhizoctonia solani, and Pythium sp. The results clearly showed that 
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transgenic plant lines ORF13 and RSL1 have substantial resistance to Sclerotinia 
sclerotiorum infection by producing significantly smaller symptom area compared to 
control vector plant line 1234 and WT. The statistical analyzes confirmed the results of the 
bioassay. Estimated least square mean p-values respectively for the varieties RSL1(0.0055) 
and ORF1 (0.0444) showed significant difference in the infected area comparing to the 
control WT. Similar result was observed with RSL1 variety which demonstrated less 
susceptibility to the pathogen. Estimated p-values RSL1 (0.0399) indicated substantial 
difference comparing to the transgenic control variety 1234. 
 The experiments with the other two pathogens Rhizoctonia solani, and Pythium sp.  did 
not develop significant smaller necrotic area comparing to two controls.  Statistical analysis 
also confirmed these results.  
In conclusion, non-plant multi-lytic peptide confers resistance against Sclerotinia 
sclerotiorum, causing economically important white mold infection on plants. Further 
studies are necessary to confirm the potential of the non-plant multi-lytic peptides for 
control of plant diseases.  
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